Chronic Lymphocytic Leukemia ... : News

Healthline's Premium Tools

Symptom Search
Discover possible causes based on the symptoms you enter. It's fast, convenient and easy to use.
Pill Finder
Search by color, shape and markings. click here
Drug Interaction Checker
Check any 2 drugs for interactions. click here
Drug Compare
Compare any two drugs side by side. click here
Healthline Part D Plan Selector Medicare Part D
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
... chair ... innocently commanding everyone's attention. Bonnie Goodhart, in an often painful day-to-day battle with chronic lymphocytic leukemia for five years now, finally had something to say. Everyone listened, too. "I just wish there was a way we ...
Source:The Mercury
Date:September 4, 2008
For the first time researchers have proved that there is a genetic susceptibility to developing chronic lymphocytic leukaemia , the most common form of leukaemia in the Western world.
Source:MediLexicon
Date:September 1, 2008
Abstract Leukemia-cell expression of ZAP-70, CD38, or unmutated immunoglobulin heavy chain variable region genes each is associated with aggressive disease in patients with chronic lymphocytic leukemia .
Source:CiteULike
Date:August 29, 2008
... cyclophosphamide, and rituximab (FCR) regimen in 224 patients showed that it was highly active as initial therapy of chronic lymphocytic leukemia. In this report, we present the final results of all 300 study patients at a median follow up of 6 ...
Source:CiteULike
Date:August 29, 2008
Main Category: Lymphoma / Leukemia Also Included In: Cancer / Oncology ; Clinical Trials / Drug Trials Article Date: 27 Aug 2008 - 0:00 PDT Genmab A/S announced plans to begin four studies of ofatumumab in ...
Source:Medical News ToMedical News Today
Date:August 27, 2008
... drug designation for multiple myeloma (MM) in the EU, US, Australia and Switzerland, and orphan drug designation for chronic lymphocytic leukemia (CLL) in the EU and US. REVLIMID is currently approved for use in the US and Canada for the treatment ...
Source:MediLexicon
Date:August 26, 2008
... million) was triggered by the achievement of positive results in the Phase III study of ofatumumab in refractory chronic lymphocytic leukemia (CLL). Genmab has received an approximate total of DKK 552 million (approximately USD 110 million) in ...
Source:PR Newswire
Date:August 21, 2008
... Current clinical programs with MaxCyte-engineered cells include: a Phase IIa clinical study for treatment of Chronic Lymphocytic Leukemia (CLL) and a Phase IIa study using engineered stem cells for the treatment of primary Pulmonary Arterial ...
Source:Rehab Management
Date:August 20, 2008
A Complimentary Continuing Education Monograph VOORHEES, N.J., Aug. 14 /PRNewswire/ -- Chronic lymphocytic leukemia and acute myelogenous leukemia are the two most common types of leukemia diagnosed in adults ...
Source:PR Newswire
Date:August 14, 2008
... blessing, but this knowledge will help you to work around the issue with maximum effect. One more important thing - leukemia today is not a death sentence by default, like it used to be. We tell that not to give a false hope or over-encourage ...
Source:Shaister.com
Date:August 11, 2008
Main Category: Lymphoma / Leukemia Also Included In: Pharma Industry / Biotech Industry GlaxoSmithKline and Genmab A/S announced today positive top-line results from an interim analysis of the Phase III pivotal ...
Source:MediLexicon
Date:August 9, 2008
... M.D., Stephen J. Richards, Ph.D., Andrew S. Jack, Ph.D., and Peter Hillmen, Ph.D. ABSTRACT Background A diagnosis of chronic lymphocytic leukemia (CLL) requires a count of over 5000 circulating CLL-phenotype cells per cubic millimeter. Asymptomatic ...
Source:New England Journal of Medicine
Date:August 6, 2008
Advertisement
Back to Top